Qraft Ai pilot US Large Cap Dynamic Beta and Income ETF (AIDB) Quote

Thanks Testpilot,

I have no knowledge of how long these things take, or of Ford's intentions. Frankly I planned on purchasing a 2025 Mustang Mach E when I heard they'd have the better battery tech in the long range, but I couldn't pass up the discount on a Lexus RZ I was offered. It

BREAKING: 9th Circuit Court of Appeals Rules mRNA COVID-19 Jab is NOT a Vaccine Under Traditional Medical Definitions
by Jim Hoft
June 8, 2024

https://www.thegatewaypundit.com/2024/06/breaking-9th-circuit-court-appeals-rules-mrna-covid/

The United States C

So, the company has:
$11 million in equity
$50 million dollar agreement signed with the First Nations of Canada (that includes $1 million in cash paid to RONN as a gesture of good faith)
Company is at MINIMUM WORTH $61 million!!!!!!!!!!
$61 million divided by 872,800,000

https://youtu.be/IeDMnyQzS88?si=EeCouORcablp-AEN

Management has failed to deliver shareholder value in a few years! Patience?!! Lol

Exactly. Glad to see your post again my friend.
BS... you knew it that there is no R/S on the table for weeks.

Second P1 was the small UPenn ovarian trial. :)

You seem extra hot on this in recent? One of 2 things....1st,I think true...you hate Parks...lol...2nd,this is ready to pop... either way,you have personal interest here...

For what it's worth Flipper:
“DEDUCED RECKONING: Northwest Biotherapeutics is finally ready for prime time”
https://eu.heraldtribune.com/story/business/2020/10/14/deduced-reckoning-northwest-biotherapeutics-ready-prime-time/3656047001/

volume_up

i-MERGE, the former joint venture between Verizon (VZ) and Lucent, was established in 2000 to provide comprehensive business communication solutions. It aimed to leverage the strengths of both companies to deliver advanced networking and communication services to large enter

You guys can blab/insult back and forth all day long about what is or isn't a pdk, or when is a pdk "complete", "functional", etc. Nobody here knows or can say defect rates, failure rates, lifetimes of finished transceivers., or what's accceptable to the Tier 1's to sign a deal, pay royalties, and

Yes.

New here ...Anyone in / familiar with RDGL ? Similar companies working on the same things ? They have 2X the OS of PPCB and are 100X pps at .17 I'll do more DD when time permits. TIA.

Moronius Simpletus

GSK/(PFE)/(MRNA)—FDA_lowers_youngest_age_for Arexvy to 50—(rather than 60):

https://www.businesswire.com/news/home/20240606055012/en The regulatory application was supported by positive results from a phase III trial (https://www.clinicaltrials.gov/study/NCT05590403 ) evaluating the

Some more positive news I can verify and is 100% accurate. The UK contingent are throwing skin back in the game starting Monday! They can virtually double their position since they left at $4.50.

GSK/(PFE)/(MRNA)—FDA_lowers_youngest_age_for Arexvy to 50—(rather than 60):

https://www.businesswire.com/news/home/20240606055012/en The regulatory application was supported by positive results from a phase III trial (https://www.clinicaltrials.gov/study/NCT05590403 ) evaluating the

Well. Not the best close for the week IMO. I guess know the levels. Make a plan. Stick with it. Change it. Just have one! Can't wait for profitability on the balance sheet!

Don't suffer fools.

Big Money Monday is upon us, see you @
https://www.forbes.com/billionaires/

I called my pharmacist. The rumor is we are getting the generic vascepa from Amarin starting July. This is a good move irrespective of the skinny label outcome of the court, imo